News Articles

With Another Phase III Trial, BNAC Solidifies Imaging Expertise

Monday, June 5th, 2017

UB’s Buffalo Neuroimaging Analysis Center (BNAC) played a pivotal role in a phase III clinical trial of the first transcatheter cerebral embolic protection (TCEP) device to obtain marketing clearance by the Food and Drug Administration.